Corvus Pharmaceuticals, Inc. (CRVS) Earnings
|
Expand Research on CRVS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -6.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/26  |
Q425 | N/A | -$0.13 | N/A | N/A | $775K | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.13 | N/A | N/A | $775K | N/A | N/A | N/A | ||
| 3/5/26 |
Q425 | N/A | -$0.13 | N/A | N/A | $775K | N/A | N/A | N/A | ||
| 11/4/25 | Q325 | -$0.12 | -$0.13 | +$0.01 | N/A | N/A | N/A |  | | Details | |
| 8/7/25 | Q225 | -$0.10 | -$0.13 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 5/8/25 | Q125 | -$0.13 | -$0.12 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 3/25/25 | Q424 | -$0.18 | -$0.12 | -$0.06 | N/A | N/A | N/A | | | Details | |
| 3/19/25 |
Q424 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A |
